Literature DB >> 2454948

Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis.

S Brul1, A Westerveld, A Strijland, R J Wanders, A W Schram, H S Heymans, R B Schutgens, H van den Bosch, J M Tager.   

Abstract

We have used complementation analysis after somatic cell fusion to investigate the genetic relationships among various genetic diseases in humans in which there is a simultaneous impairment of several peroxisomal functions. The activity of acyl-coenzyme A:dihydroxyacetonephosphate acyltransferase, which is deficient in these diseases, was used as an index of complementation. In some of these diseases peroxisomes are deficient and catalase is present in the cytosol, so that the appearance of particle-bound catalase could be used as an index of complementation. The cell lines studied can be divided into at least five complementation groups. Group 1 is represented by a cell line from a patient with the rhizomelic form of chondrodysplasia punctata. Group 2 consists of cell lines from four patients with the Zellweger syndrome, a patient with the infantile form of Refsum disease and a patient with hyperpipecolic acidemia. Group 3 comprises one cel line from a patient with the Zellweger syndrome, group 4 one cell line from a patient with the neonatal form of adrenoleukodystrophy, and group 5 one cell line from a patient with the Zellweger syndrome. We conclude that at least five genes are required for the assembly of a functional peroxisome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454948      PMCID: PMC442615          DOI: 10.1172/JCI113510

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Infantile Refsum disease: deficiency of catalase-containing particles (peroxisomes), alkyldihydroxyacetone phosphate synthase and peroxisomal beta-oxidation enzyme proteins.

Authors:  R J Wanders; R B Schutgens; G Schrakamp; H van den Bosch; J M Tager; A W Schram; T Hashimoto; B T Poll-Thé; J M Saudubrau
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

2.  Determining optimal therapy--randomized trials in individual patients.

Authors:  J A Smyth
Journal:  N Engl J Med       Date:  1986-09-18       Impact factor: 91.245

3.  Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome.

Authors:  S Goldfischer; C L Moore; A B Johnson; A J Spiro; M P Valsamis; H K Wisniewski; R H Ritch; W T Norton; I Rapin; L M Gartner
Journal:  Science       Date:  1973-10-05       Impact factor: 47.728

4.  Cell-free synthesis of the enzymes of peroxisomal beta-oxidation.

Authors:  S Furuta; T Hashimoto; S Miura; M Mori; M Tatibana
Journal:  Biochem Biophys Res Commun       Date:  1982-03-30       Impact factor: 3.575

Review 5.  Peroxisomes (microbodies) in cell pathology.

Authors:  S Goldfischer; J K Reddy
Journal:  Int Rev Exp Pathol       Date:  1984

Review 6.  Biogenesis of peroxisomes.

Authors:  P B Lazarow; Y Fujiki
Journal:  Annu Rev Cell Biol       Date:  1985

7.  Degradation of cholesterol to propionic acid by rat liver peroxisomes.

Authors:  L R Hagey; S K Krisans
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

8.  Peroxisomal localization of alanine: glyoxylate aminotransferase in human liver.

Authors:  T Noguchi; Y Takada
Journal:  Arch Biochem Biophys       Date:  1979-09       Impact factor: 4.013

9.  Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway.

Authors:  A K Hajra; J E Bishop
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

10.  A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

Authors:  P B Lazarow; C De Duve
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

View more
  34 in total

1.  Disorders of peroxisome biogenesis: complementation analysis shows genetic heterogeneity with strong overrepresentation of one group (PEX1 deficiency).

Authors:  R J Wanders; P A Mooijer; C Dekker; Y Suzuki; N Shimozawa
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

Review 2.  Peroxisomal disorders: clinical, biochemical, and molecular aspects.

Authors:  R J Wanders
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells.

Authors:  S Yajima; Y Suzuki; N Shimozawa; S Yamaguchi; T Orii; Y Fujiki; T Osumi; T Hashimoto; H W Moser
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

4.  Bifunctional enzyme deficiency: identification of a new type of peroxisomal disorder in a patient with an impairment in peroxisomal beta-oxidation of unknown aetiology by means of complementation analysis.

Authors:  R J Wanders; C W van Roermund; S Brul; R B Schutgens; J M Tager
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 5.  The surprising complexity of peroxisome biogenesis.

Authors:  L J Olsen
Journal:  Plant Mol Biol       Date:  1998-09       Impact factor: 4.076

Review 6.  Diagnostic work-up of a peroxisomal patient.

Authors:  J G Leroy; M Espeel; J F Gadisseux; H Mandel; M Martinez; B T Poll-The; R J Wanders; F Roels
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect.

Authors:  N Shimozawa; Y Suzuki; T Orii; A Moser; H W Moser; R J Wanders
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

8.  Peroxisome assembly factor 1: nonsense mutation in a peroxisome-deficient Chinese hamster ovary cell mutant and deletion analysis.

Authors:  T Tsukamoto; N Shimozawa; Y Fujiki
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

Review 9.  Peroxisomal disorders: a review.

Authors:  B Fournier; J A Smeitink; L Dorland; R Berger; J M Saudubray; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

10.  Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders.

Authors:  C C Chang; S J Gould
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.